HIV research yields potential drug target

SAN ANTONIO — Humans possess a formidable multi-layered defense system that protects us against viral infections. Better understanding of these defenses and the tricks that viruses use to evade them could open novel avenues for treating viral infections and possibly other diseases. For example, a human protein called SAMHD1 impedes replication of the human immunodeficiency…

Details

Rabies treatment demonstrated as safe and effective for use in children in first pediatric trial

A treatment, known as KEDRAB (Rabies Immune Globulin [Human]), currently used in the prevention of rabies has been demonstrated to be safe and effective for patients age 17 and under. Results published today in Human Vaccines & Immunotherapeutics report the first and only pediatric trial of any human rabies immunoglobulin (HRIG) currently available in the…

Details

How research on chronic illnesses will improve COVID-19 treatment

A new paper in Oxford Open Immunology, published by Oxford University Press, examines prior findings in the field of neuroimmunology that suggest potential treatment strategies for patients suffering long-term symptoms from COVID-19. Though COVID-19 was initially believed to be a short-term illness, lasting between one and three weeks, it’s clear that a substantial number of…

Details

Why Black men’s prostate cancer may be more responsive to immunotherapy

Increased level of plasma cells linked to improved cancer survival 1,300 prostate tumor samples studied Immunotherapy-based precision medicine clinical trials being developed CHICAGO— Black men die more often of prostate cancer yet, paradoxically, have greater survival benefits from immunotherapy treatment. A new Northwestern Medicine study discovered the reason appears to be an increase of…

Details

Lundquist Institute receives $1.75 million grant from Steven & Alexandra Cohen Foundation

LOS ANGELES (February 10, 2021) — The Lundquist Institute has received a $1.75 million grant from the Steven & Alexandra Cohen Foundation to fund a multi-site clinical trial to evaluate the efficacy and safety of the compound psilocybin in individuals with severe psychological distress associated with a terminal medical illness. The grant will also support…

Details